Growth Metrics

Indivior Pharmaceuticals (INDV) Exchange Rate Effect (2022 - 2025)

Indivior Pharmaceuticals has reported Exchange Rate Effect over the past 4 years, most recently at -$2.0 million for Q3 2025.

  • For Q3 2025, Exchange Rate Effect fell 100.0% year-over-year to -$2.0 million; the TTM value through Mar 2026 reached -$1.0 million, down 150.0%, while the annual FY2025 figure was -$1.0 million, N/A changed from the prior year.
  • Exchange Rate Effect for Q3 2025 was -$2.0 million at Indivior Pharmaceuticals, down from $1.0 million in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $2.0 million in Q4 2023 and troughed at -$2.0 million in Q3 2025.
  • A 4-year average of $0.0 and a median of $0.0 in 2022 define the central range for Exchange Rate Effect.
  • Biggest five-year swings in Exchange Rate Effect: surged 100.0% in 2023 and later tumbled 100.0% in 2025.
  • Year by year, Exchange Rate Effect stood at $1.0 million in 2022, then surged by 100.0% to $2.0 million in 2023, then plummeted by 50.0% to $1.0 million in 2024, then tumbled by 300.0% to -$2.0 million in 2025.
  • Business Quant data shows Exchange Rate Effect for INDV at -$2.0 million in Q3 2025, $1.0 million in Q2 2025, and $1.0 million in Q4 2024.